Cargando…
Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice
OBJECTIVE: To investigate the role of (188)Re in human sodium iodide symporter (hNIS) theranostic gene-mediated human glioma imaging and therapy in model mice. METHODS: The human glioma cell line U87 was transfected with recombinant lentivirus encoding the hNIS gene under the control of cytomegalovi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084984/ https://www.ncbi.nlm.nih.gov/pubmed/25000403 http://dx.doi.org/10.1371/journal.pone.0102011 |
_version_ | 1782324585407971328 |
---|---|
author | Guo, Rui Zhang, M. Xi, Yun Ma, Yufei Liang, Sheng Shi, Shuo Miao, Ying Li, Biao |
author_facet | Guo, Rui Zhang, M. Xi, Yun Ma, Yufei Liang, Sheng Shi, Shuo Miao, Ying Li, Biao |
author_sort | Guo, Rui |
collection | PubMed |
description | OBJECTIVE: To investigate the role of (188)Re in human sodium iodide symporter (hNIS) theranostic gene-mediated human glioma imaging and therapy in model mice. METHODS: The human glioma cell line U87 was transfected with recombinant lentivirus encoding the hNIS gene under the control of cytomegalovirus promoter (U87-hNIS). The uptake and efflux of (188)Re were determined after incubating the cells with (188)Re. (188)Re uptake experiments in the presence of various concentrations of sodium perchlorate were carried out. In vitro cell killing tests with (188)Re were performed. U87-hNIS mediated (188)Re distribution, imaging and therapy in nude mice were also tested. RESULTS: U87-hNIS cell line was successfully established. The uptake of (188)Re in U87-hNIS cells increased up to 26-fold compared to control cells, but was released rapidly with a half-life of approximately 4 minutes. Sodium perchlorate reduced hNIS-mediated (188)Re uptake to levels of control cell lines. U87-hNIS cells were selectively killed following exposure to (188)Re, with a survival of 21.4%, while control cells had a survival of 92.1%. Unlike in vitro studies, U87-hNIS tumor showed a markedly increased (188)Re retention even 48 hours after (188)Re injection. In the therapy study, there was a significant difference in tumor size between U87-hNIS mice (317±67 mm(3)) and control mice (861±153 mm(3)) treated with (188)Re for 4 weeks (P<0.01). CONCLUSION: The results indicate that inserting the hNIS gene into U87 cells is sufficient to induce specific (188)Re uptake, which has a cell killing effect both in vitro and in vivo. Moreover, our study, based on the function of hNIS as a theranostic gene allowing noninvasive imaging of hNIS expression by (188)Re scintigraphy, provides detailed characterization of in vivo vector biodistribution and level, localization, essential prerequisites for precise planning and monitoring of clinical gene therapy that aims to individualize gene therapy concept. |
format | Online Article Text |
id | pubmed-4084984 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40849842014-07-09 Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice Guo, Rui Zhang, M. Xi, Yun Ma, Yufei Liang, Sheng Shi, Shuo Miao, Ying Li, Biao PLoS One Research Article OBJECTIVE: To investigate the role of (188)Re in human sodium iodide symporter (hNIS) theranostic gene-mediated human glioma imaging and therapy in model mice. METHODS: The human glioma cell line U87 was transfected with recombinant lentivirus encoding the hNIS gene under the control of cytomegalovirus promoter (U87-hNIS). The uptake and efflux of (188)Re were determined after incubating the cells with (188)Re. (188)Re uptake experiments in the presence of various concentrations of sodium perchlorate were carried out. In vitro cell killing tests with (188)Re were performed. U87-hNIS mediated (188)Re distribution, imaging and therapy in nude mice were also tested. RESULTS: U87-hNIS cell line was successfully established. The uptake of (188)Re in U87-hNIS cells increased up to 26-fold compared to control cells, but was released rapidly with a half-life of approximately 4 minutes. Sodium perchlorate reduced hNIS-mediated (188)Re uptake to levels of control cell lines. U87-hNIS cells were selectively killed following exposure to (188)Re, with a survival of 21.4%, while control cells had a survival of 92.1%. Unlike in vitro studies, U87-hNIS tumor showed a markedly increased (188)Re retention even 48 hours after (188)Re injection. In the therapy study, there was a significant difference in tumor size between U87-hNIS mice (317±67 mm(3)) and control mice (861±153 mm(3)) treated with (188)Re for 4 weeks (P<0.01). CONCLUSION: The results indicate that inserting the hNIS gene into U87 cells is sufficient to induce specific (188)Re uptake, which has a cell killing effect both in vitro and in vivo. Moreover, our study, based on the function of hNIS as a theranostic gene allowing noninvasive imaging of hNIS expression by (188)Re scintigraphy, provides detailed characterization of in vivo vector biodistribution and level, localization, essential prerequisites for precise planning and monitoring of clinical gene therapy that aims to individualize gene therapy concept. Public Library of Science 2014-07-07 /pmc/articles/PMC4084984/ /pubmed/25000403 http://dx.doi.org/10.1371/journal.pone.0102011 Text en © 2014 Guo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Guo, Rui Zhang, M. Xi, Yun Ma, Yufei Liang, Sheng Shi, Shuo Miao, Ying Li, Biao Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice |
title | Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice |
title_full | Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice |
title_fullStr | Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice |
title_full_unstemmed | Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice |
title_short | Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using (188)Re: A Human Glioma Study in Mice |
title_sort | theranostic studies of human sodium iodide symporter imaging and therapy using (188)re: a human glioma study in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084984/ https://www.ncbi.nlm.nih.gov/pubmed/25000403 http://dx.doi.org/10.1371/journal.pone.0102011 |
work_keys_str_mv | AT guorui theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice AT zhangm theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice AT xiyun theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice AT mayufei theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice AT liangsheng theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice AT shishuo theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice AT miaoying theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice AT libiao theranosticstudiesofhumansodiumiodidesymporterimagingandtherapyusing188reahumangliomastudyinmice |